Spinal cord stimulator (SCS) is a Federal Drug Administration-approved treatment modality for treating failed back surgery syndrome (FBSS), complex regional pain syndrome (CRPS), and diabetic neuropathy (DN). Patients first must undergo an SCS trial by placing electrodes in the epidural space with a temporary external power source to determine if the patient achieves pain relief. The pulses generated by the SCS create paresthesias to interfere with the pain. If the trial is successful, a permanent SCS is implanted. Despite using paresthesias in low-frequency SCS treatment, many patients find this uncomfortable. To avoid using paresthesias with low frequency, a newer, higher frequency version using a waveform of 10 kHz at a subthreshold level can provide superior pain relief without paresthesias. Additionally, high-frequency SCS may be used to salvage therapy where low-frequency SCS has failed. Here, we present a case where we switched mid-trial from low-frequency to high-frequency SCS with lead placement revision salvaging the trial and improving the patient’s overall pain.